ARCHIVES

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

This article is from The Cancer Letter archive.

Vol. 24 No. 10 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

CCRU RFA Reissued, Outstanding Investigator Grants Now Available, CCSPs Changed To Program Projects

April 20, 1984

Two Phase II Studies of Ibrutinib Deliver High Response Rates

December 27, 2013

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

March 5, 1999

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012

NCI to Undergo More GAO Probes

July 15, 1977

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014